In addition, Mcl-1 and Noxa expression may serve as potential markers for PI activity in pancreatic cancer cells, however, their predictive value needs further clinical confirmation, just as delineating the role of autophagy in pancreatic cancer cells and novel therapeutic approaches with PI-conjugated nanoparticles. The gene discussed is PMAIP1; the disease is familial pancreatic carcinoma.